THAMES AVE SURGERY — All Prescriptions & Medications — Page 3
Practice Code: G82154 | GILLINGHAM, ME8 9BW
Showing results 101-150 of 484
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Insulin glargine | 194 | 1,247 | £10.4K | -31.7% ▼ |
| Esomeprazole | 191 | 11.5K | £642 | -52.8% ▼ |
| Spironolactone | 185 | 10.1K | £585 | -65.7% ▼ |
| Levetiracetam | 184 | 16.6K | £3.0K | -59.8% ▼ |
| Oxycodone hydrochloride | 179 | 19.8K | £5.7K | -30.1% ▼ |
| Linagliptin | 176 | 9,352 | £10.6K | -57.0% ▼ |
| Topiramate | 175 | 15.0K | £2.0K | -1.5% vs avg |
| Sumatriptan succinate | 174 | 1,348 | £349 | -50.9% ▼ |
| 173 | 21.6K | £830 | -63.5% ▼ | |
| Fluticasone furoate | 170 | 179 | £1.1K | -12.2% ▼ |
| Nifedipine | 168 | 13.8K | £2.5K | -10.4% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 168 | 33.2K | £3.1K | -25.7% ▼ |
| Hyoscine butylbromide | 165 | 11.3K | £919 | -29.2% ▼ |
| Quetiapine | 165 | 7,059 | £2.7K | -73.5% ▼ |
| Doxycycline hyclate | 165 | 1,890 | £181 | -67.8% ▼ |
| Semaglutide | 164 | 3,721 | £14.0K | -31.9% ▼ |
| Escitalopram | 163 | 5,852 | £707 | -42.7% ▼ |
| Mebeverine hydrochloride | 160 | 15.8K | £521 | -48.5% ▼ |
| Enalapril maleate | 158 | 9,842 | £321 | -12.1% ▼ |
| Irbesartan | 155 | 9,604 | £418 | -36.4% ▼ |
| Bendroflumethiazide | 154 | 8,619 | £136 | -80.1% ▼ |
| Dexamethasone | 154 | 800 | £499 | -10.4% ▼ |
| Baclofen | 153 | 21.2K | £534 | -23.6% ▼ |
| Famotidine | 151 | 10.4K | £5.8K | -69.1% ▼ |
| Loperamide hydrochloride | 148 | 13.7K | £292 | -36.5% ▼ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 148 | 4,556 | £464 | -3.1% ▼ |
| Pramipexole | 147 | 4,452 | £757 | +49.7% ▲ |
| Chloramphenicol | 145 | 1,186 | £648 | +26.6% ▲ |
| Tolterodine | 144 | 4,846 | £1.8K | -3.1% ▼ |
| Methylphenidate hydrochloride | 143 | 5,645 | £6.3K | -44.6% ▼ |
| Diazepam | 137 | 1,870 | £51 | -72.5% ▼ |
| Nystatin | 135 | 4,140 | £238 | +33.9% ▲ |
| Carbamazepine | 132 | 16.0K | £1.0K | -55.5% ▼ |
| Empagliflozin | 131 | 7,084 | £8.8K | -79.1% ▼ |
| 131 | 15.0K | £649 | -52.6% ▼ | |
| 131 | 19.3K | £1.0K | +0.0% vs avg | |
| 131 | 975 | £353 | -37.3% ▼ | |
| Lercanidipine hydrochloride | 130 | 7,616 | £763 | -79.0% ▼ |
| Methotrexate | 129 | 4,098 | £244 | -60.4% ▼ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 128 | 139 | £2.0K | +12.9% ▲ |
| Eplerenone | 127 | 5,754 | £719 | -52.1% ▼ |
| Buprenorphine | 126 | 564 | £2.0K | -65.6% ▼ |
| Clobetasone butyrate | 124 | 4,740 | £1.5K | -39.2% ▼ |
| Nortriptyline | 121 | 9,079 | £1.2K | -16.8% ▼ |
| 121 | 28.5K | £2.0K | +19.1% ▲ | |
| 120 | 124 | £699 | -49.2% ▼ | |
| Edoxaban | 118 | 6,188 | £10.3K | -83.2% ▼ |
| Hydrocortisone | 117 | 2,764 | £672 | +54.0% ▲ |
| Mometasone furoate | 117 | 4,900 | £554 | -12.5% ▼ |
| Fusidic acid | 117 | 2,655 | £324 | -8.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.